Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Memantine versus placebo for craving and impulsivity in opioid use disorder during withdrawal recovery
IRCT20260713070165N1Phase 3Recruiting
- Sponsor
- Shahid Sadoughi University of Medical Sciences
- Start
- Aug 2026
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in opioid use disorder (OUD) comparing Memantine with Placebo (2 arms). Primary endpoints: Craving intensity, Consumption and 3 more. Started Aug 2026; status: recruiting.
02
Drugs
memantine
03
Conditions
opioid use disorder (OUD)
Beyond the preview
Go deeper on IRCT20260713070165N1.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20260713070165N1.